| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | 31-Oct-06 | | Total Revenue | 16,625,656 | 21,826,722 | 16,197,922 | | Cost of Revenue | 6,075,412 | 8,282,859 | 5,124,479 | | | Gross Profit | 10,550,245 | 13,543,863 | 11,073,443 | | | Operating Expenses | | Research Development | 828 | 44,008 | 37,477 | | Selling General and Administrative | 5,676,508 | 6,719,541 | 5,657,182 | | Non Recurring | (10,759) | 166,600 |
-
| | Others | 1,396,161 | 928,351 | 196,306 | | | | Total Operating Expenses | 7,062,738 | 7,858,500 |
-
| | | | Operating Income or Loss | 3,487,506 | 5,685,363 | 5,182,478 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 107,923 | 96,368 | | Earnings Before Interest And Taxes | 3,561,163 | 5,747,183 | 5,294,908 | | Interest Expense | 1,921,687 | 3,237,702 | 2,211,119 | | Income Before Tax | 1,639,476 | 2,509,481 | 3,083,789 | | Income Tax Expense | (106,760) | 178,126 | 604,087 | | Minority Interest | (126,623) | (161,361) | (138,307) | | | | Net Income From Continuing Ops | 1,545,957 | 2,216,097 | 2,325,334 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,545,957 | 2,216,097 | 2,325,334 | | Preferred Stock And Other Adjustments | (60,415) | (45,055) | (26,769) | | | Net Income Applicable To Common Shares | $1,485,542 | $2,171,042 | $2,298,565 |
|
1.48% Nasdaq 
Income Statement
